Literature DB >> 28405952

Surgical management of papillary thyroid carcinoma: an overview.

Paolo Miccoli1, Sohail Bakkar2,3.   

Abstract

The surgical management of papillary thyroid carcinoma remains contentious and the optimal surgical strategy has not been yet established. The extent of thyroid resection has been the nub of this debate. Literature lacks prospective randomized controlled trials that could help put this debate to rest, and these have been labeled as being impractical. Consequently, large retrospective studies and expert opinion have constituted the basis of clinical practice guidelines. Recent American Thyroid Association and National Comprehensive Cancer Network guidelines consider a conservative approach in the form of a thyroid lobectomy sufficient for low-risk disease and that total thyroidectomy remains the standard of care in the presence of high-risk features. Nevertheless, many authorities still advocate more aggressive therapy for low-risk disease. The challenge in standardizing the surgical strategy to papillary thyroid carcinoma is mainly related to a major tumor characteristic: the high frequency of occult cancerous foci whether within the thyroid gland itself or within loco-regional lymph nodes as this tumor characteristic has been incriminated for a higher risk of recurrent disease and its adverse sequelae. The purpose of this article is to provide an overview of the surgical management of papillary thyroid carcinoma and the main arguments surrounding this hotly debated topic. All evidences for this review article were drawn from PubMed articles in English language mostly cross-referenced with international guideline statements.

Entities:  

Keywords:  Papillary thyroid carcinoma; Surgical management; Thyroid lobectomy; Total thyroidectomy

Mesh:

Year:  2017        PMID: 28405952     DOI: 10.1007/s13304-017-0449-5

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  48 in total

1.  A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study.

Authors:  Hyemi Kwon; Min Ji Jeon; Won Gu Kim; Suyeon Park; Mijin Kim; Dong Eun Song; Tae-Yon Sung; Jong Ho Yoon; Suck Joon Hong; Tae Yong Kim; Young Kee Shong; Won Bae Kim
Journal:  Eur J Endocrinol       Date:  2017-01-15       Impact factor: 6.664

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.

Authors:  Seo Ki Kim; Inhye Park; Jung-Woo Woo; Jun Ho Lee; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim
Journal:  Surgery       Date:  2016-09-01       Impact factor: 3.982

4.  Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.

Authors:  N Gopalakrishna Iyer; Luc G T Morris; R Michael Tuttle; Ashok R Shaha; Ian Ganly
Journal:  Cancer       Date:  2011-03-22       Impact factor: 6.860

Review 5.  Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: A meta-analysis.

Authors:  Francisco Igor B Macedo; Vijay K Mittal
Journal:  Surg Oncol       Date:  2015-04-22       Impact factor: 3.279

6.  Extent of thyroidectomy affects vocal and throat functions: a prospective observational study of lobectomy versus total thyroidectomy.

Authors:  Junsun Ryu; Youn Mi Ryu; Yuh-S Jung; Su-Jin Kim; You Jin Lee; Eun-Kyung Lee; Seok-Ki Kim; Tae-Sung Kim; Tae Hyun Kim; Chang Yoon Lee; Seog Yun Park; Ki Wook Chung
Journal:  Surgery       Date:  2013-08-08       Impact factor: 3.982

7.  Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons.

Authors:  Adam Hauch; Zaid Al-Qurayshi; Gregory Randolph; Emad Kandil
Journal:  Ann Surg Oncol       Date:  2014-06-19       Impact factor: 5.344

Review 8.  Comparison of Completion Thyroidectomy and Primary Total Surgery for Differentiated Thyroid Cancer: A Meta-Analysis.

Authors:  Yu-Jie Li; Yao-Zong Wang; Zhan-Bo Yi; Liang-Liang Chen; Xiao-Dong Zhou
Journal:  Oncol Res Treat       Date:  2015-09-27       Impact factor: 2.825

9.  Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.

Authors:  Kenichi Matsuzu; Kiminori Sugino; Katsuhiko Masudo; Mitsuji Nagahama; Wataru Kitagawa; Hiroshi Shibuya; Keiko Ohkuwa; Takashi Uruno; Akifumi Suzuki; Syunsuke Magoshi; Junko Akaishi; Chie Masaki; Michikazu Kawano; Nobuyasu Suganuma; Yasushi Rino; Munetaka Masuda; Kaori Kameyama; Hiroshi Takami; Koichi Ito
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

10.  Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer.

Authors:  Stéphane Bardet; Renaud Ciappuccini; Elske Quak; Jean-Pierre Rame; David Blanchard; Dominique de Raucourt; Emmanuel Babin; Jean-Jacques Michels; Dominique Vaur; Natacha Heutte
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

View more
  27 in total

1.  Improved outcomes for papillary thyroid microcarcinoma care: active surveillance and case volume.

Authors:  Francesco Freni; Bruno Galletti; Francesco Galletti; Gianlorenzo Dionigi
Journal:  Ther Adv Endocrinol Metab       Date:  2018-05-04       Impact factor: 3.565

Review 2.  Tailored surgery according to molecular analysis in differentiated thyroid carcinomas.

Authors:  Paolo Miccoli; Gabriele Materazzi; Elisabetta Macerola; Sohail Bakkar
Journal:  Gland Surg       Date:  2018-08

3.  Implications of a background of Hashimoto's thyroiditis on the current conservative surgical trend towards papillary thyroid carcinoma.

Authors:  Shadi Hamouri; Sohail Bakkar; Almoutuz Aljaafreh; Mohammed Bani Hani; Hussein Heis; Ghazi Qasaimeh; Nasr Alrabadi; Wisam Al Gargaz; Haitham Odat; Yazan Alkurdi; Tarek Manasreh; Mohammad Matalka; Moamin Badwan
Journal:  Updates Surg       Date:  2021-05-20

4.  Surgical Management of Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma. Experience in 25 Patients.

Authors:  Claudio Spinelli; Silvia Strambi; Sohail Bakkar; Andrea Nosiglia; GianMarco Elia; Alessia Bertocchini; Chiara Calani; Matteo Leoni; Riccardo Morganti; Gabriele Materazzi
Journal:  World J Surg       Date:  2020-01       Impact factor: 3.352

5.  Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.

Authors:  Dan Yi; Dongxin Zhang; Jie He
Journal:  Cell Cycle       Date:  2021-11-16       Impact factor: 4.534

Review 6.  Total thyroidectomy vs. lobectomy in differentiated thyroid cancer: is there a reasonable size cut-off for decision? A narrative review.

Authors:  Daniele Barbaro; Giancarlo Basili; Gabriele Materazzi
Journal:  Gland Surg       Date:  2021-07

7.  Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway.

Authors:  Qun-Guang Jiang; Cheng-Feng Xiong; Yun-Xia Lv
Journal:  Mol Cell Biochem       Date:  2020-11-17       Impact factor: 3.396

8.  Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer.

Authors:  Sohail Bakkar; Khaled Al-Omar; Gianluca Donatini; Qusai Aljarrah; Theodosios S Papavramidis; Gabriele Materazzi; Paolo Miccoli
Journal:  Endocrine       Date:  2021-06-10       Impact factor: 3.633

9.  BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland.

Authors:  Sohail Bakkar; Elisabetta Macerola; Qusai Aljarrah; Agnese Proietti; Gabriele Materazzi; Fulvio Basolo; Paolo Miccoli
Journal:  Updates Surg       Date:  2019-10-04

10.  Can a simple rule-out tool reliably select patients with solitary Bethesda IV nodules for conservative surgery?

Authors:  Gianluca Donatini
Journal:  Updates Surg       Date:  2021-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.